Management of intracerebral hemorrhage: can we still learn something?

Intracerebral hemorrhage (ICH) is the most devastating form of stroke. It affects approximately 2 million people worldwide every year and is a major cause of mortality and morbidity. Despite the focus of intensive scientific research on ICH for decades there is still no proven treatment strategy for...

Full description

Saved in:
Bibliographic Details
Published inNervenarzt Vol. 83; no. 12; p. 1569
Main Authors Staykov, D, Köhrmann, M, Unterberg, A
Format Journal Article
LanguageGerman
Published Germany 01.12.2012
Subjects
Antihypertensive Agents - therapeutic use
Cerebral Hemorrhage - diagnosis
Cerebral Hemorrhage - therapy
Critical Care - methods
Fibrinolytic Agents - therapeutic use
Humans
Neurosurgical Procedures - methods
Online AccessGet full text

Cover

More Information
Summary:Intracerebral hemorrhage (ICH) is the most devastating form of stroke. It affects approximately 2 million people worldwide every year and is a major cause of mortality and morbidity. Despite the focus of intensive scientific research on ICH for decades there is still no proven treatment strategy for this disease. Advances in knowledge on the underlying pathomechanisms of ICH and the clinical impact have contributed to the development of novel treatment approaches. Currently, surgical treatment, aggressive blood pressure management and intraventricular fibrinolysis in patients with additional severe intraventricular hemorrhage are being investigated in large scale phase III clinical trials.
ISSN:1433-0407
DOI:10.1007/s00115-012-3531-8